<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Doxycycline hyclate periodontal extended-release liquid: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Doxycycline hyclate periodontal extended-release liquid: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Doxycycline hyclate periodontal extended-release liquid: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11942" href="/d/html/11942.html" rel="external">see "Doxycycline hyclate periodontal extended-release liquid: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F55469111"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Atridox</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52866680"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Atridox</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F163407"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antibiotic, Tetracycline Derivative</li></ul></div>
<div class="block doa drugH1Div" id="F163398"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cfc2c6df-d6fb-4385-ac5f-32955fdd2531">Periodontitis, non-severe, plaque-associated</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Periodontitis, non-severe, plaque-associated (adjunctive agent): Subgingival: </b>
<i>Atridox subgingival controlled-release product:</i> Dose depends on size, shape, and number of pockets treated; local anesthesia is not required for placement. Each final blended syringe product formulation contains 50 mg doxycycline hyclate per 500 mg. May be repeated 4 months after initial treatment (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-manu.1'])">Ref</a></span>). Use in addition to periodontal debridement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Chow.1','lexi-content-ref-10368053','lexi-content-ref-26113100','lexi-content-ref-11442735']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Chow.1','lexi-content-ref-10368053','lexi-content-ref-26113100','lexi-content-ref-11442735'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block doe drugH1Div" id="F163399"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F163382"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Headache (27%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gastrointestinal: Minor gum irritation (18%), toothache (14%; pressure sensitivity)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cardiovascular: Hypertension (&lt;1% to 2%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Central nervous system: Local discomfort (sensitive teeth: 8%), sore mouth (4%; soft tissue erythema, unspecified pain), insomnia (3%), tension headache (2%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dermatologic: Dermatitis (1%), skin infection (1%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Endocrine &amp; metabolic: Premenstrual syndrome (4%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gastrointestinal: Periodontal abscess (10%), sore throat (6%), injury of tooth (5%), dyspepsia (4%), gingivitis (4%), diarrhea (3%), nausea (2%), periodontal abscess (2%; lesion), vomiting (2%), dental bleeding (1%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Infection: Common cold (26%), influenza (3% to 6%) ), tooth abscess (2%; pulpitis)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Neuromuscular &amp; skeletal: Myalgia (6%), back pain (4%), arm pain (2%), leg pain (2%), lower back pain (2%), muscle tenderness (2%), jaw pain (1%), neck pain (1%), shoulder pain (1%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Respiratory: Sinus congestion (6%), sinus infection (5%), cough (4%), bronchitis (2%), ENT infection (2%), allergic rhinitis (1%)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Miscellaneous: Fever (1%)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">&lt;1%, postmarketing, and/or case reports: Aphthous stomatitis, enamel hypoplasia, fistula, hypersensitivity reaction, permanent dental discoloration, skin photosensitivity, tooth loss</p></div>
<div class="block coi drugH1Div" id="F163393"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to doxycycline, tetracycline or any component of the formulation; children &lt;8 years of age.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Canadian labeling:</i> Additional contraindications (not in US labeling): Children &lt;12 years of age; pregnancy; breastfeeding.</p></div>
<div class="block war drugH1Div" id="F163379"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Photosensitivity: May cause photosensitivity; discontinue if skin erythema occurs. Use skin protection and avoid prolonged exposure to sunlight; do not use tanning equipment.</p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: May cause tissue hyperpigmentation, enamel hypoplasia, or permanent tooth discoloration; use of tetracyclines should be avoided during tooth development (children &lt;8 years of age) unless other drugs are not likely to be effective or are contraindicated.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For subgingival application: This product has not been evaluated or tested in immunocompromised patients, in patients with oral candidiasis, or in conditions characterized by severe periodontal defects with little remaining periodontium. May result in overgrowth of nonsusceptible organisms, including fungi. Effects of treatment &gt;9 months have not been evaluated. Has not been evaluated for use in regeneration of alveolar bone.</p></div>
<div class="block foc drugH1Div" id="F55469112"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Gel, Mouth/Throat:</p>
<p style="text-indent:-2em;margin-left:4em;">Atridox: 42.5 mg/0.5 mL (0.5 mL)</p></div>
<div class="block geq drugH1Div" id="F163376"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block dinfoc drugH1Div" id="F52866681"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, Mouth/Throat: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Atridox: 44 mg/0.5 mL (0.5 mL)</p></div>
<div class="block adm drugH1Div" id="F163390"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">Atridox subgingival controlled-release product: The delivery system consists of 2 separate syringes in a single pouch. Syringe A contains 450 mg of a bioabsorbable polymer gel; syringe B contains doxycycline hyclate 50 mg. If refrigerated, remove the product from refrigeration at least 15 minutes prior to mixing.</p>
<p style="text-indent:-2em;margin-left:2em;">To prepare for instillation, couple syringe A to syringe B. Inject contents of syringe A (red stripe) into syringe B, then push contents back into syringe A. Repeat this mixing cycle at a rate of one cycle per second for 100 cycles. If syringes are stored prior to use (a maximum of 3 days), repeat mixing cycle 10 times before use. After appropriate mixing, contents should be in syringe A. Holding syringes vertically, with syringe A at the bottom, pull back on the syringe A plunger, allowing contents to flow down barrel for several seconds. Uncouple syringes and attach enclosed blunt cannula to syringe A. Local anesthesia is not required for placement. Cannula tip may be bent to resemble periodontal probe and used to explore pocket. Express product from syringe until pocket is filled. To separate tip from formulation, turn tip towards the tooth and press against tooth surface to achieve separation. An appropriate dental instrument may be used to pack gel into the pocket. Pockets may be covered with either Coe-Pak or Octyldent dental adhesive.</p></div>
<div class="block use drugH1Div" id="F163389"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Periodontitis, non-severe, plaque-associated:</b> Treatment of chronic adult periodontitis for a gain in clinical attachment, reduction in probing depth, and reduction in bleeding on probing (John 2017).</p></div>
<div class="block cyt drugH1Div" id="F13299234"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F163383"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F13882183"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Tetracyclines cross the placenta (Mylonas 2011). Tetracyclines accumulate in developing teeth and long tubular bones. Permanent discoloration of teeth (yellow, gray, brown) can occur following in utero exposure and is more likely to occur following long-term or repeated exposure. Serum concentrations following subgingival use are significantly less than with oral tablets. Use of this product should be avoided in pregnant patients unless other options are not likely to be effective or are contraindicated.</p>
<p style="text-indent:0em;margin-top:2em;">Refer to the Doxycycline monograph for additional information.</p></div>
<div class="block brc drugH1Div" id="F13882184"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if doxycycline is present in breast milk following subgingival application.</p>
<p style="text-indent:-2em;margin-left:2em;">Doxycycline is present in breast milk following systemic use. Due to the potential for serious adverse reactions in the breastfed infant, the manufacturer recommends a decision be made to discontinue breastfeeding or to discontinue the drug, considering the importance of treatment to the mother.</p>
<p style="text-indent:-2em;margin-left:2em;">Refer to the Doxycycline monograph for additional information.</p></div>
<div class="block pha drugH1Div" id="F163378"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Inhibits protein synthesis by binding with the 30S and possibly the 50S ribosomal subunit(s) of susceptible bacteria; may also cause alterations in the cytoplasmic membrane </p>
<p style="text-indent:0em;margin-top:2em;text-align:justify;">Doxycycline inhibits collagenase <i>in vitro</i> and has been shown to inhibit collagenase in the gingival crevicular fluid in adults with periodontitis</p></div>
<div class="block phk drugH1Div" id="F163392"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Systemic absorption from dental subgingival gel may occur, but is limited by the slow rate of dissolution from this formulation over 7 days.</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Atridox (doxycycline hyclate 10%) [prescribing information]. Fort Collins, CO: Tolmar Inc; October 2016.</div>
</li>
<li>
<div class="reference">
                  Atridox (doxycycline hyclate controlled-release gel) [product monograph]. Mississauga, Ontario, Canada: Radiant Global Logistics; July 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Chow.1">
<a name="Chow.1"></a>Chow AW. Complications, diagnosis, and treatment of odontogenic infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 9, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10368053">
<a name="10368053"></a>Garrett S, Johnson L, Drisko CH, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. <i>J Periodontol</i>. 1999;70(5):490-503. doi:10.1902/jop.1999.70.5.490<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/doxycycline-hyclate-periodontal-extended-release-liquid-drug-information/abstract-text/10368053/pubmed" id="10368053" target="_blank">10368053</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28370333">
<a name="28370333"></a>John MT, Michalowicz BS, Kotsakis GA, Chu H. Network meta-analysis of studies included in the clinical practice guideline on the nonsurgical treatment of chronic periodontitis. <i>J Clin Periodontol</i>. 2017;44(6):603-611. doi:10.1111/jcpe.12726<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/doxycycline-hyclate-periodontal-extended-release-liquid-drug-information/abstract-text/28370333/pubmed" id="28370333" target="_blank">28370333</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20814687">
<a name="20814687"></a>Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. <i>Arch Gynecol Obstet</i>. 2011;283(1):7-18. doi:10.1007/s00404-010-1646-3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/doxycycline-hyclate-periodontal-extended-release-liquid-drug-information/abstract-text/20814687/pubmed" id="20814687" target="_blank">20814687</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26113100">
<a name="26113100"></a>Smiley CJ, Tracy SL, Abt E, et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. <i>J Am Dent Assoc</i>. 2015;146(7):525-535. doi:10.1016/j.adaj.2015.01.026<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/doxycycline-hyclate-periodontal-extended-release-liquid-drug-information/abstract-text/26113100/pubmed" id="26113100" target="_blank">26113100</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Vibramycin (doxycycline capsules) [prescribing information]. New York, NY: Pfizer Labs; October 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11442735">
<a name="11442735"></a>Wennström JL, Newman HN, MacNeill SR, et al. Utilisation of locally delivered doxycycline in non-surgical treatment of chronic periodontitis. A comparative multi-centre trial of 2 treatment approaches. <i>J Clin Periodontol</i>. 2001;28(8):753-761. doi:10.1034/j.1600-051x.2001.280806.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/doxycycline-hyclate-periodontal-extended-release-liquid-drug-information/abstract-text/11442735/pubmed" id="11442735" target="_blank">11442735</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 8905 Version 91.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
